Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial

Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T16:55:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new collaborators and a revision number change, while extensive details about the study's methodology and participant criteria have been removed.
    Difference
    9%
    Check dated 2025-04-16T12:40:22.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-01-28.
    Difference
    0.1%
    Check dated 2025-04-09T06:40:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 28, 2025, and version 2.14.2.
    Difference
    0.0%
    Check dated 2025-04-01T22:49:21.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The webpage has added helpful links provided by the National Institute of Allergy and Infectious Diseases (NIAID), which may enhance the resourcefulness of the page.
    Difference
    0.1%
    Check dated 2025-03-11T04:15:32.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.2%
    Check dated 2025-02-24T20:25:59.000Z thumbnail image

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.